Oncostatin M: A pleiotropic cytokine in the central nervous system

Cytokine and Growth Factor Reviews

Volumn 15, Issue 5, 2004, Pages 379-391

  Chen, Shao Hua ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Brain tumors; Central nervous system; Glial cells; Oncostatin M; Signal transduction

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR; GLYCOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; JANUS KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; PROSTAGLANDIN E2; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; VASCULOTROPIN;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ASTROCYTE; ASTROCYTOMA; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOPHYSIS ADENOMA; IMMUNOREACTIVITY; LEUKOCYTE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-6; MICE; ONCOSTATIN M; PEPTIDES; PROTEIN-TYROSINE KINASES; RECEPTORS, CYTOKINE; RECEPTORS, ONCOSTATIN M; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

JANUS;

EID: 4344596581     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2004.06.002     Document Type: Review

References (118)

1. J.M. Zarling, M. Shoyab, H. Marquardt, M.B. Hanson, M.N. Lioubin, and G.J. Todaro Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells Proc. Natl. Acad. Sci. U.S.A. 83 1986 9739 9743
2. P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Müller-Newen, and F. Schaper Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem. J. 374 2003 1 20
3. T.M. Rose, and A.G. Bruce Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6 Proc. Natl. Acad. Sci. U.S.A. 88 1991 8641 8645
4. R.C. Hoffman, F.J. Moy, V. Price, J. Richardson, D. Kaubisch, and E.A. Frieden Resonance assignments for oncostatin M, a 24-kDa alpha-helical protein J. Biomol. NMR 7 1996 273 282
5. N. Malik, J.C. Kallestad, N.L. Gunderson, S.D. Austin, M.G. Neubauer, and V. Ochs Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M Mol. Cell. Biol. 9 1989 2847 2853
6. P.S. Linsley, J. Kallestad, V. Ochs, and M. Neubauer Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M Mol. Cell. Biol. 10 1990 1882 1890
7. A.G. Bruce, I.H. Hoggatt, and T.M. Rose Oncostatin M is a differentiation factor for myeloid leukemia cells J. Immunol. 149 1992 1271 1275
8. I. Dunham, N. Shimizu, B.A. Roe, S. Chissoe, A.R. Hunt, and J.E. Collins The DNA sequence of human chromosome 22 Nature 402 1999 489 495
9. T.M. Rose, M.J. Lagrou, I. Fransson, B. Werelius, O. Delattre, and G. Thomas The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22 Genomics 17 1993 136 140
10. F. Ensoli, V. Fiorelli, M. DeCristofaro, D.S. Muratori, A. Novi, and B. Vannelli Inflammatory cytokines and HIV-1 associated neurodegeneration: oncostatin M produced by mononuclear cells from HIV-1 infected individuals induces apoptosis of primary neurons J. Immunol. 162 1999 6268 6277
11. M. Hasegawa, S. Sato, H. Ihn, and K. Takehara Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis Rheumatology 38 1999 612 617
12. S.F. Radka, S. Nakamura, S. Sakurada, and S.Z. Salahuddin Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma J. Immunol. 150 1993 5195 5201
13. T.J. Brown, M.N. Lioubin, and H. Marquardt Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes J. Immunol. 139 1987 2977 2983
14. H.E. Broxmeyer, H.A. Bruns, S. Zhang, S. Cooper, G. Hangoc, and A.N.J. McKenzie Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M Immunity 16 2002 815 825
15. A. Grenier, M. Dehoux, A. Boutten, M. Arce-Vicioso, G. Durand, and M.-A. Gougerot-Pocidalo Oncostain M production and regulation by human polymorphonuclear neutrophils Blood 93 1999 1413 1421
16. A. Grenier, D. Combaux, J. Chastre, M.A. Gougerot-Pocidalo, C. Gibert, and M. Dehoux Oncostatin M production by blood and alveolar neutrophils during acute lung injury Lab. Invest. 81 2001 133 141
17. G. Lisignoli, A. Piacentini, S. Toneguzzi, F. Grassi, B. Cocchini, and A. Ferruzzi Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inibitory factor and oncostatin M Clin. Exp. Immunol. 119 2000 346 353
18. A. Hong, M. Zhang, B. Leigh, and G. Stevens Induction of interleukin-6 and oncostatin M by radiation in Kaposi's sarcoma cell lines Int. J. Radiat. Oncol. Biol. Phys. 50 2001 533 540
19. T. Suda, K. Chida, A. Todate, K. Ide, K. Asada, and Y. Nakamura Oncostatin M production by human dendritic cells in response to bacterial products Cytokine 17 2002 335 340
20. M.P. De Miguel, J. Regadera, F. Martinez-Garcia, M. Nistal, and R. Paniagua Oncostatin M in the normal human testis and several testicular disorders J. Biol. Chem. 84 1999 768 774
21. 2 is a novel inducer of oncostatin M expression in macrophages and microglia J. Neurosci. 22 2002 5334 5343
22. K. Ruprecht, T. Kuhlmann, F. Seif, V. Hummel, N. Kruse, and W. Bruck Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions J. Neuropathol. Exp. Neurol. 60 2001 1087 1098
23. Y. Ma, R.J. Streiff, J. Liu, M.J. Spence, and R.E. Vestal Cloning and characterization of human oncostatin M promoter Nucleic Acids Res. 27 1999 4649 4657
24. J. Komorowski, G. Gradowski, and H. Stepien Effects of human chorionic gonadotropin (hCG) and β-hCG on oncostatin M release from human peripheral blood mononuclear cells in vitro Cytobios 92 1997 159 163
25. A. Sodhi, S. Shishodia, and A. Shrivastava Cisplatin-stimulated murine bone marrow-derived macrophages secrete oncostatin M Immunol. Cell Biol. 75 1997 492 496
26. F. Ensoli, V. Fiorelli, A. Lugaresi, D. Farina, M. De Cristofaro, and B. Collacchi Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors α and β, and interferon γ Mult. Scler. 8 2002 284 288
27. J. Vecchiet, M. Dalessandro, K. Falasca, A. Di Iorio, F. Travasi, and P. Zingariello Increased production of oncostatin M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS J. Acquir. Immune Defic. Syndr. 32 2003 464 465
28. A. Lilja, C. Nordborg, A. Brun, L.G. Salford, and P. Åman Expression of the IL-6 family cytokines in human brain tumors Int. J. Oncol. 19 2001 495 499
29. C. Hao, I.F. Parney, W.H. Roa, J. Turner, K.C. Petruk, and D.A. Ramsay Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation Acta Neuropathol. 103 2002 171 178
30. P. Repovic, C.Y. Fears, C.L. Gladson, and E.N. Benveniste Oncostatin M induction of vascular endothelial growth factor expression in astroglioma cells Oncogene 22 2003 8117 8124
31. J.L. Jankowsky, and P.H. Patterson Differential regulation of cytokine expression following pilocarpine-induced seizure Exp. Neurol. 159 1999 333 346
32. D.R. Rosell, J. Nacher, K.T. Akama, and B.S. McEwen Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation Neuroscience 122 2003 329 348
33. A. Hanisch, K.D. Dieterich, K. Dietzmann, K. Ludecke, M. Buchfelder, and R. Fahlbusch Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas J. Clin. Endocrinol. Metab. 85 2000 4411 4414
34. Y. Ito, M. Yamamoto, M. Li, N. Mitsuma, F. Tanaka, and M. Doyu Temporal expression of mRNAs for neuropoietic cytokines, interleukin-11 (IL-11), oncostatin M (OSM), cardiotrophin-1 (CT-1) and their receptors (IL-11Rα and OSMRβ) in peripheral nerve injury Neurochem. Res. 25 2000 1113 1118
35. B. Thoma, T.A. Bird, D.J. Friend, D.P. Gearing, and S.K. Dower Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes J. Biol. Chem. 269 1994 6215 6222
36. D.P. Gearing, and A.G. Bruce Oncostatin M binds the high-affinity leukemia inhibitory factor receptor New Biol. 4 1992 61 65
37. B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, and L.S. Park Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation J. Biol. Chem. 271 1996 32635 32643
38. M. Tanaka, and A. Miyajima Oncostatin M, a multifunctional cytokine Rev. Physiol. Biochem. Pharmacol. 149 2003 39 52
39. L.K. Schaefer, S. Wang, and T.S. Schaefer Oncostatin M activates STAT DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of STAT activation Cytokine 12 2000 1647 1655
40. N.J. Van Wagoner, C. Choi, P. Repovic, and E.N. Benveniste Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38 J. Neurochem. 75 2000 563 575
41. C.A. O'Brien, and S.C. Manolagas Isolation and characterization of the human gp130 promoter J. Biol. Chem. 272 1997 15003 15010
42. F. Blanchard, Y. Wang, E. Kinzie, L. Duplomb, A. Godard, and H. Baumann Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms J. Biol. Chem. 276 2001 47038 47045
43. J-G. Zhang, A. Farley, S.E. Nicholson, T.A. Willson, L.M. Zugaro, and R.J. Simpson The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation Proc. Natl. Acad. Sci. U.S.A. 96 1999 2071 2076
44. M. Ichihara, T. Hara, H. Kim, T. Murate, and A. Miyajima Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice Blood 90 1997 165 173
45. R.A. Lindberg, TS-C. Juan, A.A. Welcher, Y. Sun, R. Cupples, and B. Guthrie Cloning and characterization of a specific receptor for mouse oncostatin M Mol. Cell. Biol. 18 1998 3357 3367
46. F. Aloisi, F. Ria, and L. Adorini Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes Immunol. Today 21 2000 141 147
47. S. Tamura, Y. Morikawa, and E. Senba Localization of oncostatin M receptor beta in adult and developing CNS Neuroscience 119 2003 991 997
48. S. Tamura, Y. Morikawa, A. Miyajima, and E. Senba Expression of oncostatin M receptor beta in a specific subset of nociceptive sensory neurons Eur. J. Neurosci. 17 2003 2287 2298
49. K. Nakashima, S. Wiese, M. Yanagisawa, H. Arakawa, N. Kimura, and T. Hisatsune Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation J. Neurosci. 19 1999 5429 5434
50. C.B. Ware, M.C. Horowitz, B.R. Renshaw, J.S. Hunt, D. Liggitt, and S.A. Koblar Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death Development 121 1995 1283 1299
51. K. Yoshida, T. Taga, M. Saito, S. Suematsu, A. Kumanogoh, and T. Tanka Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders Proc. Natl. Acad. Sci. U.S.A. 93 1996 407 411
52. M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima Targeted disruption of oncostatin M receptor results in altered hematopoiesis Blood 102 2003 3154 3162
53. W. Zhu, T. Mustelin, and M. David Arginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatase J. Biol. Chem. 277 2002 35787 35790
54. R.N. Freiman, and R. Tjian Regulating the regulators: lysine modifications make their mark Cell 112 2003 11 17
55. R.L. Haspel, and J.E. Darnell Jr. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1 Proc. Natl. Acad. Sci. U.S.A. 96 1999 10188 10193
56. K. Shuai, and B. Liu Regulation of JAK-STAT signalling in the immune system Nat. Rev. Immunol. 3 2003 900 911
57. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635
58. M.H. Heim, I.M. Kerr, G.R. Stark, and J.E. Darnell Jr. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway Science 267 1995 1347 1349
59. E. Korzus, H. Nagase, R. Rydell, and J. Travis The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression J. Biol. Chem. 272 1997 1188 1196
60. 2 and cyclooxygenase-2 in astrocytes Glia 42 2003 433 446
61. S. Radtke, H.M. Hermanns, C. Haan, H. Schmitz-Van De Leur, H. Gascan, and P.C. Heinrich Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression J. Biol. Chem. 277 2002 11297 11305
62. S.H. Yang, A.D. Sharrocks, and A.J. Whitmarsh Transcriptional regulation by the MAP kinase signaling cascades Gene 320 2003 3 21
63. J.M. English, and M.H. Cobb Pharmacological inhibitors of MAPK pathways Trends Pharmacol. Sci. 23 2002 40 45
64. W.Q. Li, F. Dehnade, and M. Zafarullah Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway J. Immunol. 166 2001 3491 3498
65. J.A. Hutt, and J.W. DeWille Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein δ-dependent pathway Mol. Cancer Ther. 1 2002 601 610
66. F. Zhang, C. Li, H. Halfter, and J. Liu Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells Oncogene 22 2003 894 905
67. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu. Rev. Pharmacol. Toxicol. 38 1998 97 120
68. 2 in rat astrocyte cultures: modulatory effect of neuropeptides Endocrinology 124 1989 3125 3127
69. Z. Fabry, C.S. Raine, and M.N. Hart Nervous tissue as an immune compartment: the dialect of the immune response in the CNS Immunol. Today 15 1994 218 224
70. G.R. John, S.C. Lee, and C.F. Brosnan Cytokines: powerful regulators of glial cell activation Neuroscientist 9 2003 10 22
71. E.N. Benveniste, V.T. Nguyen, and G.M. O'Keefe Immunological aspects of microglia: relevance to Alzheimer's disease Neurochem. Int. 39 2001 381 391
72. G.R. John, L. Chen, M.A. Rivieccio, C.V. Melendez-Vasquez, A. Hartley, and C.F. Brosnan Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis J. Neurosci. 24 2004 2837 2845
73. M. Rostworowski, V. Balasingam, S. Chabot, T. Owens, and V.W. Yong Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma J. Neurosci. 17 1997 3664 3674
74. R.S. Ghirnikar, Y.L. Lee, and L.F. Eng Inflammation in traumatic brain injury: role of cytokines and chemokines Neurochem. Res. 23 1998 329 340
75. F.M. Brennan, and M. Feldmann Cytokines in autoimmunity Curr. Opin. Immunol. 8 1996 872 877
76. P.M. Wallace, J.F. MacMaster, K.A. Rouleau, T.J. Brown, J.K. Loy, and K.L. Donaldson Regulation of inflammatory responses by oncostatin M J. Immunol. 162 1999 5547 5555
77. R.M. Ransohoff, C.L. Howe, and M. Rodriguez Growth factor treatment of demyelinating disease: at last, a leap into the light Trends Immunol. 23 2002 512 516
78. R.A. Linker, M. Mäurer, S. Gaupp, R. Martini, B. Holtmann, and R. Giess CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation Nat. Med. 8 2002 620 624
79. H. Butzkueven, J-G. Zhang, M. Soilu-Hanninen, H. Hochrein, F. Chionh, and K.A. Shipham LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival Nat. Med. 8 2002 613 619
80. B. Hemmer, J.J. Archelos, and H-P. Hartung New concepts in the immunopathogenesis of multiple sclerosis Nat. Rev. Neurosci. 3 2002 291 301
81. B. Stankoff, M-S. Aigrot, F. Noël, A. Wattilliaux, B. Zalc, and C. Lubetzki Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules J. Neurosci. 22 2002 9221 9227
82. N. Malik, H.S. Haugen, B. Modrell, M. Shoyab, and C.H. Clegg Developmental abnormalities in mice transgenic for bovine oncostatin M Mol. Cell. Biol. 15 1995 2349 2358
83. Y. Morikawa, S. Tamura, K. Minehata, P.J. Donovan, A. Miyajima, and E. Senba Essential function of oncostatin M in nociceptive neurons of dorsal root ganglia J. Neurosci. 24 2004 1941 1947
84. S.L. Grant, and C.G. Begley The oncostatin M signalling pathway: reversing the neoplastic phenotype? Mol. Med. Today 5 1999 406 412
85. H. Halfter, J. Kremerskothen, J. Weber, U. Hacker-Klom, A. Barnekow, and E.B. Ringelstein Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor J. Neurooncol. 39 1998 1 18
86. H. Halfter, R. Lotfi, R. Westermann, P. Young, E.B. Ringelstein, and F.T. Stögbauer Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM) Growth Factors 15 1998 135 147
87. M. Friedrich, N. Höss, F. Stögbauer, V. Senner, W. Paulus, and E.B. Ringelstein Complete inhibition of in vivo glioma growth by oncostatin M J. Neurochem. 76 2001 1589 1592
88. B. Barleon, S. Sozzani, D. Zhou, H.A. Weich, A. Mantovani, and D. Marmé Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336 3343
89. N. Ferrara Molecular and biological properties of vascular endothelial growth factor J. Mol. Med. 77 1999 527 543
90. M. Sondell, G. Lundborg, and M. Kanje Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system J. Neurosci. 19 1999 5731 5740
91. K.L. Jin, X.O. Mao, and D.A. Greenberg Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc. Natl. Acad. Sci. U.S.A. 97 2000 10242 10247
92. W.T. Monacci, M.J. Merrill, and E.H. Oldfield Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues Am. J. Physiol. 264 1993 C995 C1002
93. E. Papavassiliou, N. Gogate, M. Proescholdt, J.D. Heiss, S. Walbridge, and N.A. Edwards Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain J. Neurosci. Res. 49 1997 451 460
94. W. Gu, T. Brënnström, W. Jiang, A. Bergh, and P. Wester Vascular endothelial growth factor-A and -C protein up-regulation and early angiogenesis in a rat photothrombotic ring stroke model with spontaneous reperfusion Acta Neuropathol. (Berl.) 102 2001 216 226
95. M. Sköld, S. Cullheim, H. Hammarberg, F. Piehl, A. Suneson, and S. Lake Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration Eur. J. Neurosci. 12 2000 3675 3686
96. J. Vaquero, M. Zurita, and C. Morales Possible role for vascular permeability factor in the pathophysiology of vasogenic oedema associated to brain abscess Acta Neurochir. 143 2001 1039 1040
97. H. Huber, A. Eggert, A.J. Janss, R. Wiewrodt, H. Zhao, and L.N. Sutton Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas Eur. J. Cancer 37 2001 2064 2072
98. G. Nagashima, R. Suzuki, J-I. Asai, and T. Fujimoto Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases Clin. Neurol. Neurosurg. 104 2002 125 131
99. I.H. Chaudhry, D.G. O'Donovan, P.E.C. Brenchley, H. Reid, and I.S. Roberts Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas Histopathology 39 2001 409 415
100. T. Pietsch, M.M. Valter, H.K. Wolf, A. von Deimling, H.-J.S. Huang, and W.K. Cavenee Expression and distribution of vascular endothelial growth factor protein in human brain tumors Acta Neuropathol. (Berl.) 93 1997 109 117
101. Y. Yao, T. Kubota, K. Sato, R. Kitai, H. Takeuchi, and H. Arishima Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours Acta Neurochir. 143 2001 159 166
102. D.E. Gomez, D.F. Alonso, H. Yoshiji, and U.P. Thorgeirsson Tissue inhibitors of metalloproteinases: structure, regulation and biological functions Eur. J. Cell Biol. 74 1997 111 122
103. A. Kasza, D.L. Kiss, S. Gopalan, W. Xu, R.E. Rydel, and A. Koj Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes J. Neurochem. 83 2002 696 703
104. M. Bugno, B. Witek, J. Bereta, M. Bereta, D.R. Edwards, and T. Kordula Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines FEBS Lett. 448 1999 9 14
105. E. Muir, J.S. Du, J. Fok-Seang, L.C. Smith-Thomas, E.S. Housden, and J. Rogers Increased axon growth through astrocyte cell lines transfected with urokinase Glia 23 1998 24 34
106. C.L. Gladson, J.E. Stewart Jr., M.A. Olman, P.L. Chang, L.M. Schnapp, and J.R. Grammer Attachment of primary neonatal rat astrocytes to vitronectin is mediated by integrins αvβ5 and α8β1: modulation by the type 1 plasminogen activator inhibitor Neurosci. Lett. 283 2000 157 161
107. 1-antichymotrypsin expression in human cortical astrocytes J. Biol. Chem. 273 1998 4112 4118
108. A. Yoshimura, T. Ohkubo, T. Kiguchi, N.A. Jenkins, D.J. Gilbert, and N.G. Copeland A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors EMBO J. 14 1995 2816 2826
109. W.S. Alexander Suppressors of cytokine signalling (SOCS) in the immune system Nat. Rev. Immunol. 2 2002 410 416
110. H. Yasukawa, H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, and T. Wakioka The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop EMBO J. 18 1999 1309 1320
111. J. Wang, and I.L. Campbell Cytokine signaling in the brain: putting a SOCS in it? J. Neurosci. Res. 67 2002 423 427
112. C. Bousquet, C. Susini, and S. Melmed Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor J. Clin. Invest. 104 1999 1277 1285
113. R. Starr, T.A. Willson, E.M. Viney, Murray LJL, J.R. Rayner, and B.J. Jenkins A family of cytokine-inducible inhibitors of signalling Nature 387 1997 917 921
114. J. Schmitz, M. Weissenbach, S. Haan, P.C. Heinrich, and F. Schaper SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130 J. Biol. Chem. 275 2000 12848 12856
115. F. Magrangeas, O. Boisteau, S. Denis, Y. Jacques, and S. Minvielle Negative regulation of oncostatin M signaling by suppressor of cytokine signaling (SOCS-3) Eur. Cytokine Netw. 12 2001 309 315
116. K. Mahboubi, N.C. Kirkiles-Smith, J. Karras, and J.S. Pober Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3 J. Biol. Chem. 278 2003 25014 25023
117. C.D. Chung, J. Liao, B. Liu, X. Rao, P. Jay, and P. Berta Specific inhibition of Stat3 signal transduction by PIAS3 Science 278 1997 1803 1805
118. B. Liu, J. Liao, X. Rao, S.A. Kushner, C.D. Chung, and D.D. Chang Inhibition of Stat1-mediated gene activation by PIAS1 Proc. Natl. Acad. Sci. U.S.A. 95 1998 10626 10631